IRIS Accounts Production v23.2.0.158 04484729 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh044847292022-03-31044847292023-03-31044847292022-04-012023-03-31044847292021-03-31044847292021-04-012022-03-31044847292022-03-3104484729ns10:Originalns15:EnglandWales2022-04-012023-03-3104484729ns14:PoundSterlingns10:Original2022-04-012023-03-3104484729ns10:Originalns10:Director12022-04-012023-03-3104484729ns10:Original2022-04-012023-03-3104484729ns10:Original2023-03-3104484729ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3104484729ns10:Originalns10:SmallEntities2022-04-012023-03-3104484729ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3104484729ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3104484729ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3104484729ns10:Originalns10:FullAccounts2022-04-012023-03-3104484729ns10:Originalns10:Director22022-04-012023-03-3104484729ns10:CompanySecretary1ns10:Original2022-04-012023-03-3104484729ns10:Originalns10:RegisteredOffice2022-04-012023-03-3104484729ns10:Original2022-03-3104484729ns10:Originalns5:CurrentFinancialInstruments2023-03-3104484729ns10:Originalns5:CurrentFinancialInstruments2022-03-3104484729ns10:Originalns5:Non-currentFinancialInstruments2023-03-3104484729ns10:Originalns5:Non-currentFinancialInstruments2022-03-3104484729ns5:ShareCapitalns10:Original2023-03-3104484729ns5:ShareCapitalns10:Original2022-03-3104484729ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3104484729ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3104484729ns10:Originalns5:PlantMachinery2022-04-012023-03-3104484729ns10:Originalns5:FurnitureFittings2022-04-012023-03-3104484729ns10:Original2021-04-012022-03-3104484729ns10:Originalns5:PlantMachinery2022-03-3104484729ns10:Originalns5:FurnitureFittings2022-03-3104484729ns10:Original2022-03-3104484729ns10:Originalns5:PlantMachinery2023-03-3104484729ns10:Originalns5:FurnitureFittings2023-03-3104484729ns10:Originalns5:PlantMachinery2022-03-3104484729ns10:Originalns5:FurnitureFittings2022-03-3104484729ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3104484729ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3104484729ns5:Securedns10:Original2023-03-3104484729ns5:Securedns10:Original2022-03-31
REGISTERED NUMBER: 04484729 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

FOR

DNA DEVELOPMENTS LIMITED

DNA DEVELOPMENTS LIMITED (REGISTERED NUMBER: 04484729)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


DNA DEVELOPMENTS LIMITED

COMPANY INFORMATION
for the Year Ended 31 March 2023







DIRECTORS: Mr A Lynch
Mrs D Lynch





SECRETARY: Mrs D Lynch





REGISTERED OFFICE: The Barn
Green Lane
Gee Cross
Hyde
Cheshire
SK14 3BD





REGISTERED NUMBER: 04484729 (England and Wales)





ACCOUNTANTS: Moss and Williamson Limited
Chartered Accountants
11 Stamford Street
Stalybridge
Cheshire
SK15 1JP

DNA DEVELOPMENTS LIMITED (REGISTERED NUMBER: 04484729)

BALANCE SHEET
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 780 1,039
Investment property 6 250,000 250,000
250,780 251,039

CURRENT ASSETS
Debtors 7 - 215
Cash at bank 10,948 7,498
10,948 7,713
CREDITORS
Amounts falling due within one year 8 17,863 17,970
NET CURRENT LIABILITIES (6,915 ) (10,257 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

243,865

240,782

CREDITORS
Amounts falling due after more than one
year

9

-

(7,409

)

PROVISIONS FOR LIABILITIES (148 ) (197 )
NET ASSETS 243,717 233,176

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 243,617 233,076
SHAREHOLDERS' FUNDS 243,717 233,176

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DNA DEVELOPMENTS LIMITED (REGISTERED NUMBER: 04484729)

BALANCE SHEET - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 November 2023 and were signed on its behalf by:





Mr A Lynch - Director


DNA DEVELOPMENTS LIMITED (REGISTERED NUMBER: 04484729)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

DNA Developments Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of services, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Integral equipment - 25% on reducing balance
Office equipment - 25% on reducing balance

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

DNA DEVELOPMENTS LIMITED (REGISTERED NUMBER: 04484729)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2023

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

5. TANGIBLE FIXED ASSETS
Integral Office
equipment equipment Totals
£    £    £   
COST
At 1 April 2022
and 31 March 2023 7,625 1,931 9,556
DEPRECIATION
At 1 April 2022 6,607 1,910 8,517
Charge for year 254 5 259
At 31 March 2023 6,861 1,915 8,776
NET BOOK VALUE
At 31 March 2023 764 16 780
At 31 March 2022 1,018 21 1,039

6. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 April 2022
and 31 March 2023 250,000
NET BOOK VALUE
At 31 March 2023 250,000
At 31 March 2022 250,000

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors - 215

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Bank loans and overdrafts 6,210 6,760
Taxation and social security 5,867 5,818
Other creditors 5,786 5,392
17,863 17,970

DNA DEVELOPMENTS LIMITED (REGISTERED NUMBER: 04484729)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2023

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.23 31.3.22
£    £   
Bank loans - 7,409

10. SECURED DEBTS

The following secured debts are included within creditors:

31.3.23 31.3.22
£    £   
Bank loans 6,210 14,169

The bank have a legal charge over the Market Street development.

11. RELATED PARTY DISCLOSURES

During the year, total dividends of £10,000 (2022 - £20,000) were paid to the directors .